BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Sunday, May 17, 2026
Breaking News: Tracking hantavirus across the globeBreaking News: Tracking hantavirus across the globeBreaking News: Tracking hantavirus across the globe
Home » Topics » BioWorld Science

BioWorld Science
BioWorld Science RSS Feed RSS

Endocrine/Metabolic

Novo Nordisk describes new CRF2 receptor agonists for obesity and type 2 diabetes

Feb. 7, 2023
Novo Nordisk A/S has identified novel fatty acid modified urocortin 2 derivatives acting as CRF2 receptor agonists reported to be useful for the treatment of obesity and type 2 diabetes.
Read More
Neurology/Psychiatric

Otsuka divulges new compounds for ADHD

Feb. 7, 2023
Otsuka Pharmaceutical Co. Ltd. has synthesized hydrogenated quinoxalines acting as serotonin and/or norepinephrine and/or dopamine reuptake inhibitors reported to be useful for the treatment of attention deficit hyperactivity disorder (ADHD).
Read More
Cancer

Wigen Biomedicine patents new Wee1 inhibitors for cancer

Feb. 7, 2023
Wigen Biomedicine Technology (Shanghai) Co. Ltd. has disclosed fused ring compounds acting as Wee1-like protein kinase (Wee1) inhibitors reported to be useful for the treatment of cancer.
Read More
Brain and DNA
Neurology/Psychiatric

Altered Wnt signaling and synapse loss in aging and AD models linked to the LRP6-Val variant

Feb. 7, 2023
The canonical Wnt signaling pathway participates in synapse function and stability, and previous research confirmed its impairment in Alzheimer's disease (AD).
Read More
3D representation of tumor microenvironment
Cancer

Prognostic significance of soft tissue sarcoma intratumoral viral microbiome

Feb. 7, 2023
Previous studies have revealed that the microbiome plays a role in the development and progression of some cancers and gut microbiome has been linked with immune homeostasis as well as antitumor immune responses. In the current study, scientists at the University of California, Davis aimed to evaluate the intratumoral microbiome in patients with nonmetastatic soft tissue sarcoma (STS) undergoing neoadjuvant radiotherapy (RT) and surgery.
Read More
Diagram of how cells take up glucose from the stomach and insulin from the pancreas
Endocrine/Metabolic

ALDH1A3 inhibition restores β-cell dysfunction in diabetes

Feb. 7, 2023
Insulin secretion by pancreatic β cells is a fundamental component of glucose homeostasis. Aldehyde dehydrogenase 1 family member A3 (ALDH1A3) is a molecule involved in pancreatic β-cell dedifferentiation, leading to cell failure, and a marker of type 2 diabetes progression.
Read More
Antibodies attacking cancer cell
Immuno-oncology

Atreca and Xencor select first collaborative program combining Atreca antibodies and Xencor CD3 bispecific engineering

Feb. 7, 2023
Atreca Inc. and Xencor Inc. have mutually selected the first program from their strategic collaboration combining an Atreca-discovered antibody with Xencor's Xmab bispecific Fc domain and a cytotoxic T-cell binding domain (CD3).
Read More
Immuno-oncology

Harbour Biomed's HBM-1022 targeting CCR8 cleared to enter clinic for solid tumors

Feb. 7, 2023
Harbour Biomed Ltd. has received IND clearance by the FDA to initiate clinical trials in the U.S. with HBM-1022, a monoclonal antibody generated from Harbour's integrated G protein-coupled receptor (GPCR) platform. The antibody can enhance antitumor immunity by depleting CCR8 positive regulatory T cells, activating effector T cells.
Read More
Fertility art concept
Endocrine/Metabolic

FER1L5 is indispensable for acrosome reaction and male fertility in mice

Feb. 7, 2023
Ferlins are a family of single transmembrane proteins with multiple calcium ion (Ca2+) binding C2 domains involved in Ca2+-mediated membrane fusion. Among other processes, ferlins participate in the acrosome reaction occurring before spermatozoa fuse with eggs. Mutations in ferlins have been shown to cause male infertility in Caenorhabditis elegans and Drosophila melanogaster.
Read More
Doctor examining child in wheelchair
Neurology/Psychiatric

Satellos' studies in mouse model of Duchenne muscular dystrophy support development of SAT-3153

Feb. 7, 2023
Satellos Bioscience Inc. has reported results from preclinical studies in a disease model of Duchenne muscular dystrophy (DMD). The company's proprietary Myoregenx assay platform identified a protein kinase (K9) as a potential drug target to modulate polarity in muscle stem cells.
Read More
Previous 1 2 … 1190 1191 1192 1193 1194 1195 1196 1197 1198 … 18070 18071 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for May 15, 2026.
  • Illustration of a glowing circle to represent circRNA

    ASGCT 2026: Circular RNA, the new beast in gene and cell therapy

    BioWorld
    Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
  • Test tubes, dropper and capsules

    Advancing the 'best of both' – BMS, Hengrui enter $15.2B deal

    BioWorld
    In a deal potentially worth up to $15.2 billion, Jiangsu Hengrui Pharmaceuticals Co. Ltd. is joining efforts with Bristol Myers Squibb Co. to advance 13 early...
  • 3D illustration of adeno-associated viruses

    ASGCT 2026: Uncovering the mechanisms of AAV toxicity

    BioWorld
    Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...
  • Amyloid plaques on nerve cell

    Roche secures CE mark for Alzheimer’s blood test

    BioWorld
    Roche Holding AG secured CE marking for the Elecsys plasma phosphorylated-tau 217 blood test designed to rule in and rule out amyloid pathology, a hallmark of...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing